219 related articles for article (PubMed ID: 1327841)
1. Pharmacological studies on CCKB receptors in guinea pig synaptoneurosomes.
Galas MC; Bernad N; Martinez J
Eur J Pharmacol; 1992 May; 226(1):35-41. PubMed ID: 1327841
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line.
Lignon MF; Bernad N; Martinez J
Eur J Pharmacol; 1993 May; 245(3):241-6. PubMed ID: 8335062
[TBL] [Abstract][Full Text] [Related]
3. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
Corringer PJ; Weng JH; Ducos B; Durieux C; Boudeau P; Bohme A; Roques BP
J Med Chem; 1993 Jan; 36(1):166-72. PubMed ID: 8421283
[TBL] [Abstract][Full Text] [Related]
4. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
[TBL] [Abstract][Full Text] [Related]
5. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
Corp ES; McQuade J; Moran TH; Smith GP
Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
Boyle SJ; Tang KW; Woodruff GN; McKnight AT
Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
[TBL] [Abstract][Full Text] [Related]
7. Correlation between phospholipid breakdown, intracellular calcium mobilization and enzyme secretion in rat pancreatic acini treated with Boc-[Nle28, Nle31]-CCK-7 and JMV180, two cholecystokinin analogues.
Lignon MF; Galas MC; Rodriguez M; Martinez J
Cell Signal; 1990; 2(4):339-46. PubMed ID: 1701321
[TBL] [Abstract][Full Text] [Related]
8. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
9. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
Mosher JT; Johnson MF; Birkemo LS; Ervin GN
Peptides; 1996; 17(3):483-8. PubMed ID: 8735976
[TBL] [Abstract][Full Text] [Related]
10. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.
Staley J; Jensen RT; Moody TW
Peptides; 1990; 11(5):1033-6. PubMed ID: 2178246
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
Ballaz S; Barber A; Fortuño A; Del Río J; Martin-Martínez M; Gómez-Monterrey I; Herranz R; González-Muñiz R; García-López MT
Br J Pharmacol; 1997 Jun; 121(4):759-67. PubMed ID: 9208145
[TBL] [Abstract][Full Text] [Related]
12. CCK-8-related C-terminal tetrapeptides: affinities for central CCKB and peripheral CCKA receptors.
Harhammer R; Schäfer U; Henklein P; Ott T; Repke H
Eur J Pharmacol; 1991 Dec; 209(3):263-6. PubMed ID: 1797567
[TBL] [Abstract][Full Text] [Related]
13. The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice.
Hernando F; Fuentes JA; Roques BP; Ruiz-Gayo M
Eur J Pharmacol; 1994 Aug; 261(3):257-63. PubMed ID: 7813546
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells.
Meyer G; Beinborn M; Sewing KF
Pharmacology; 1996 Jul; 53(1):48-59. PubMed ID: 8875601
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
Harper EA; Griffin EP; Shankley NP; Black JW
Br J Pharmacol; 1999 Mar; 126(6):1496-503. PubMed ID: 10217545
[TBL] [Abstract][Full Text] [Related]
16. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
O'Neill MF; Dourish CT; Iversen SD
Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
[TBL] [Abstract][Full Text] [Related]
17. CCKA and CCKB receptor subtypes both mediate the effects of CCK-8 on myenteric neurons in the guinea-pig ileum.
Schutte IW; Akkermans LM; Kroese AB
J Auton Nerv Syst; 1997 Dec; 67(1-2):51-9. PubMed ID: 9470144
[TBL] [Abstract][Full Text] [Related]
18. Biological effects of newly synthesized cholecystokinin analogs.
Verspohl EJ; LaMura M
Horm Res; 2000; 53(4):177-84. PubMed ID: 11044801
[TBL] [Abstract][Full Text] [Related]
19. His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity.
Jagerschmidt A; Guillaume-Rousselet N; Vikland ML; Goudreau N; Maigret B; Roques BP
Eur J Pharmacol; 1996 Jan; 296(1):97-106. PubMed ID: 8720482
[TBL] [Abstract][Full Text] [Related]
20. CCK-8, CCK-4 and gastrin-induced contractions in guinea pig ileum: evidence for differential release of acetylcholine and substance P by CCK-A and CCK-B receptors.
Lucaites VL; Mendelsohn LG; Mason NR; Cohen ML
J Pharmacol Exp Ther; 1991 Feb; 256(2):695-703. PubMed ID: 1704435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
